Evelina Miele
- Cancer Research top 2%
- MicroRNA in disease regulation 19
- Genetics top 2%
- Glioma Diagnosis and Treatment 45
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 20
- Hedgehog Signaling Pathway Studies 17
- Developmental Neuroscience top 5%
- Neurology top 5%
- Neuroblastoma Research and Treatments 23
- Neurofibromatosis and Schwannoma Cases 9
-
- Sarcoma Diagnosis and Treatment 14
-
- Meningioma and schwannoma management 7
- Co-authors
- Elisabetta FerrettiAgnese PòAlberto GulinoIsabella ScrepantiAngela MastronuzziEnrico De SmaeleLucia Di MarcotullioAndrea Carai
- Journals
- Nature Communications (2 papers)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Evelina Miele
112 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 110
- Cancer Research 799
- Genetics 528
- Molecular Biology 1.5k
- Developmental Neuroscience 79
- Neurology 237
Countries citing papers authored by Evelina Miele
This map shows the geographic impact of Evelina Miele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evelina Miele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evelina Miele more than expected).
Fields of papers citing papers by Evelina Miele
This network shows the impact of papers produced by Evelina Miele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evelina Miele. The network helps show where Evelina Miele may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Evelina Miele, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 12 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 11 | |
| 10 | 2021 | 6 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 11 | |
| 14 | 2018 | 56 | |
| 15 | 2018 | 16 | |
| 16 | 2014 | 142 | |
| 17 | 2013 | 28 | |
| 18 | Trastuzumab in metastatic breast cancer. | 2006 | 1 |
| 19 | [Breast carcinoma in young women]. | 2006 | 1 |
| 20 | 2006 | 5 |
About Evelina Miele
Evelina Miele is a scholar working on Genetics, Cancer Research and Neurology, having authored 121 papers that have together received 2.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (45 papers), Neuroblastoma Research and Treatments (23 papers), Epigenetics and DNA Methylation (20 papers), MicroRNA in disease regulation (19 papers), Hedgehog Signaling Pathway Studies (17 papers), Sarcoma Diagnosis and Treatment (14 papers), Neurofibromatosis and Schwannoma Cases (9 papers) and Meningioma and schwannoma management (7 papers). The work is most often cited by research in Cancer Research (799 citations), Genetics (528 citations) and Molecular Biology (1.5k citations). Evelina Miele has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Elisabetta Ferretti, Agnese Pò, Alberto Gulino, Isabella Screpanti, Angela Mastronuzzi, Enrico De Smaele, Lucia Di Marcotullio, Andrea Carai, Franco Locatelli and Felice Giangaspero. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.